Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opicapone vs Extra Levodopa for Early Wearing-Off in Parkinson's Disease (ADOPTION)
NCT04821687Phase 4Completed
- Sponsor
- SK Chemicals
- Start
- Jun 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of opicapone in Parkinson's disease (PD), sponsored by SK Chemicals. Started Jun 2021; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04821687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821687.